Clinical Trial Update: Everolimus in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating everolimus for stage IV melanoma has been completed. The update summarizes the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED